Literature DB >> 19830401

[Aggressive fibromatosis (desmoid tumor) : A rare differential diagnosis of metastasis of renal cell carcinoma].

A Janitzky1, M Porsch, M Daher, D Küster, U-B Liehr.   

Abstract

We report the case of a 65-year-old woman with an aggressive fibromatosis of the rectus abdominis muscle suspicious for a metastasis of renal cell carcinoma after tumor nephrectomy 3 years previously. Aggressive fibromatoses (desmoid tumors) are rare semimalignant tumors of the connective tissue with local infiltration and destruction of tissue. Complete resection is essential to avoid tumor relapse. Aggressive fibromatosis must be considered in the differential diagnosis of renal cell carcinoma metastasis. Complete resection and subsequent radiotherapy seem to be the therapy of choice.

Entities:  

Mesh:

Year:  2010        PMID: 19830401     DOI: 10.1007/s00120-009-2135-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  16 in total

1.  [Formation of desmoids in postoperative lumbar scars--a case report].

Authors:  N Fröhlich; P Emmrich; H-E Vitzthum
Journal:  Z Orthop Ihre Grenzgeb       Date:  2005 Jan-Feb

2.  Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.

Authors:  M T Ballo; G K Zagars; A Pollack; P W Pisters; R A Pollack
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

3.  [Aggressive fibromatosis].

Authors:  O Kolokythas; H U Beulig; M Schulte; E Merkle
Journal:  Rontgenpraxis       Date:  1996-11

4.  [Desmoid tumor of the chest wall foiling surgery].

Authors:  Antonio Fimmanò; Enrico Coppola Bottazzi; Claudia Cirillo; Pasquale Tammaro; Dino Casazza
Journal:  Ann Ital Chir       Date:  2006 Mar-Apr       Impact factor: 0.766

Review 5.  Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy.

Authors:  Paul Russo; Matthew Francis O'Brien
Journal:  Urol Clin North Am       Date:  2008-11       Impact factor: 2.241

6.  Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network.

Authors:  Ann S LaCasce; Michelle E Kho; Jonathan W Friedberg; Joyce C Niland; Gregory A Abel; Maria Alma Rodriguez; Myron S Czuczman; Michael M Millenson; Andrew D Zelenetz; Jane C Weeks
Journal:  J Clin Oncol       Date:  2008-09-02       Impact factor: 44.544

7.  The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population.

Authors:  J J Reitamo; P Häyry; E Nykyri; E Saxén
Journal:  Am J Clin Pathol       Date:  1982-06       Impact factor: 2.493

Review 8.  Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors.

Authors:  Keith M Skubitz; J Carlos Manivel; Denis R Clohisy; Jerry W Frolich
Journal:  Cancer Chemother Pharmacol       Date:  2009-04-29       Impact factor: 3.333

9.  The role of imatinib mesylate in adjuvant therapy of extra-abdominal desmoid tumors.

Authors:  Markos Ioannou; Nikolaos Demertzis; Ioanna Iakovidou; Stamatios Kottakis
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

10.  [Therapeutic options for aggressive fibromatosis].

Authors:  S Altmann; O Lenz-Scharf; W Schneider
Journal:  Handchir Mikrochir Plast Chir       Date:  2008-04       Impact factor: 1.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.